MedPath

Exercise Training Intervention in Children With Type 1 Diabetes

Not Applicable
Completed
Conditions
Type 1 Diabetes Mellitus
Interventions
Behavioral: Exercise training program
Registration Number
NCT01220479
Lead Sponsor
University Hospital, Geneva
Brief Summary

Type 1 diabetes mellitus (T1DM) is associated with multiple co-morbidities, such as hypertension, dyslipidemia, coronary heart disease and osteoporosis. The foundation of these conditions lays in childhood. Exercise is known to have a positive influence on bone mineral density (BMD) and some impact on cardiovascular disease risk factors in healthy children, but little is known about these associations in children with T1DM.

The main purpose of this study is to assess the effects of a 9-month weight-bearing exercise training program on skeletal development in children with T1DM, compared to healthy subjects. The second aim is to evaluate whether the program influences also cardiovascular diseases risk factors.

This is a randomized controlled study incorporating 30 children with T1DM and 30 healthy children. Both groups are randomly divided (1:1) in an exercise or a control group: 1) exercise diabetic, 2) controls diabetic, 3) exercise healthy, 4) controls healthy.

Exercise groups participate to an identical weight-bearing exercise training program 2 x 90 minutes per week and controls are relatively inactive.

Main measures include: total body, lumbar spine and hip BMD by DXA, body fat and fat-free mass, bone biomarkers levels, resting and ambulatory blood pressure and fasting blood lipids.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
59
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control HealthyExercise training program-
Control DiabeticExercise training program-
Exercise DiabeticExercise training program-
Exercise HealthyExercise training program-
Primary Outcome Measures
NameTimeMethod
Bone mineral density and contentat 9 months

Assessment of bone mineral density (BMD) and content (BMC) at the whole body, hip and lumbar spine using DXA.

Secondary Outcome Measures
NameTimeMethod
Anthropometricsat 9 months

Body weight, height, body mass index and pubertal stage

Blood lipids levelsat 9 months

Fasting total cholesterol, LDL-Cholesterol, HDL-Cholesterol, triglycerides, lipoprotein (a), apolipoproteins A-I and B levels.

Physical activityat 9 months

Physical activity level by questionnaire and accelerometer

Nutritionat 9 months

Total energy, proteins, lipids, carbohydrates and calcium intakes using food records

Circulating bone biomarkers levelsat 9 months

Serum levels of beta-CrossLaps (CTX), N-MID-Osteocalcin (OC), N-Terminal Propeptide of Type I Collagen (PINP) and 25-OH-vitamin D (25-OH-D)

Glycated Haemoglobinat 9 months

capillary HbA1c levels

Systemic blood pressureat 9 months

Resting and 24-hour ambulatory systemic blood pressure monitoring

Body compositionat 9 months

Assessment of whole body and abdominal fat mass, and total fat-free mass using DXA.

Trial Locations

Locations (1)

University Hospital of Geneva

🇨🇭

Geneva, Switzerland

© Copyright 2025. All Rights Reserved by MedPath